Lung Cancer BCOP Exam Questions with Correct Answers| Latest Update

Lung Cancer BCOP Exam Questions with Correct Answers| Latest Update Guaranteed Success

SCLC PS 0-1 Cisplatin based regimen



SCLC PS 2-4 Lower dose Cisplatin or Carbo



SCLC brain mets WBR prior to chemo



SCLC no brain mets prophylactic cranial irradiation



When to use TKIs Mutation
Non-curative



NSCLC stage Ia/Ib No chemo



EGFR most commonly found in what subgroup Female, Asian, never smoked



NSCLC Stage IIIB (wet) All with RT
Cis/Etop 50/50
Cis/Vinblastine 100/5
Carbo/Pac 2/80



NSCLC Stage IIA, IIB, IIIA No RT
Adjuvant Cisplatin based regimen



Palliative chemo Only for PS of 0-1

, Mutation testing Only for non-squamous histology



T790M mutation (EGFR resistance mutation) Osimertinib 80 mg daily



ALK mutation 1st line Crizotinib
Ceritinib (good CNS)
Alectinib (good CNS)



ROS1 mutation 1st line Crizotinib
Ceritinib



Bevacizumab Avoid in squamous, Brain, hemoptysis



Albumin Bound Paclitaxel >70, less neuropathy, neutropenia, thrombocytopenia



Continuation therapy Bev
Pem
Gem (2B)



PD-1/PD-L1 Pembroizumab (PD-1 50% for 1st line, 1% for second line), atezolizumab,
nivolumab



Ceritinib ALK/ROS 1st line
750 mg daily



Alectinib ALK 1st line
600 mg BID